Lisa Rasbach, Ginna Purrington, Deanna Adkins, Robert Benjamin
{"title":"远程医疗促进具有不良糖尿病结局危险因素的青少年采用自动胰岛素输送系统。","authors":"Lisa Rasbach, Ginna Purrington, Deanna Adkins, Robert Benjamin","doi":"10.1177/26350106251361370","DOIUrl":null,"url":null,"abstract":"<p><p>PurposeThe purpose of this study is to assess the effects of an intensive telehealth intervention on technology adoption and glycemic control in historically marginalized youth with diabetes mellitus on Medicaid.MethodsThis quality improvement project included youth (ages 12-18) with diabetes utilizing insulin therapy. Eligible participants were diagnosed at least 12 months prior to enrollment and had an A1C ≥9%, Medicaid insurance, and willingness to use a continuous glucose monitor (CGM) and an insulin pump. Participants received scheduled weekly contact (phone/video) with a certified diabetes care and education specialist and monthly video visits with a nurse practitioner.ResultsYouth (N = 18, 61% female, 78% non-White, diabetes duration 4.6±3 years) had baseline mean A1C of 11.4% ± 2.0%; 22% were on pump therapy. There was a sustained improvement between baseline A1C (mean 11.4% ± 2.0%) and 3 months (mean 10.5% ± 2.7%; <i>P</i> = .01) and 6 months (mean 9.8% ± 2.4%, 83.6 mmol/mol; <i>P</i> = .003). Significantly more participants used pump therapy by the end (n = 16) compared to baseline (n = 4; <i>P</i> < .0001). Participants wore CGMs more at 3 (<i>P</i> = .04) and 6 months (<i>P</i> = .0004) during the intervention compared to 3 and 6 months prior.ConclusionsThis telehealth intervention provided interim improvement in A1C and increased adoption of diabetes technology in a low socioeconomic status cohort from a historically marginalized population. Ongoing monitoring is needed to evaluate the durability of this intervention.</p>","PeriodicalId":75187,"journal":{"name":"The science of diabetes self-management and care","volume":" ","pages":"497-504"},"PeriodicalIF":2.2000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Telehealth to Promote Adoption of Automated Insulin Delivery Systems in Youth With Risk Factors for Adverse Diabetes Outcomes.\",\"authors\":\"Lisa Rasbach, Ginna Purrington, Deanna Adkins, Robert Benjamin\",\"doi\":\"10.1177/26350106251361370\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>PurposeThe purpose of this study is to assess the effects of an intensive telehealth intervention on technology adoption and glycemic control in historically marginalized youth with diabetes mellitus on Medicaid.MethodsThis quality improvement project included youth (ages 12-18) with diabetes utilizing insulin therapy. Eligible participants were diagnosed at least 12 months prior to enrollment and had an A1C ≥9%, Medicaid insurance, and willingness to use a continuous glucose monitor (CGM) and an insulin pump. Participants received scheduled weekly contact (phone/video) with a certified diabetes care and education specialist and monthly video visits with a nurse practitioner.ResultsYouth (N = 18, 61% female, 78% non-White, diabetes duration 4.6±3 years) had baseline mean A1C of 11.4% ± 2.0%; 22% were on pump therapy. There was a sustained improvement between baseline A1C (mean 11.4% ± 2.0%) and 3 months (mean 10.5% ± 2.7%; <i>P</i> = .01) and 6 months (mean 9.8% ± 2.4%, 83.6 mmol/mol; <i>P</i> = .003). Significantly more participants used pump therapy by the end (n = 16) compared to baseline (n = 4; <i>P</i> < .0001). Participants wore CGMs more at 3 (<i>P</i> = .04) and 6 months (<i>P</i> = .0004) during the intervention compared to 3 and 6 months prior.ConclusionsThis telehealth intervention provided interim improvement in A1C and increased adoption of diabetes technology in a low socioeconomic status cohort from a historically marginalized population. Ongoing monitoring is needed to evaluate the durability of this intervention.</p>\",\"PeriodicalId\":75187,\"journal\":{\"name\":\"The science of diabetes self-management and care\",\"volume\":\" \",\"pages\":\"497-504\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The science of diabetes self-management and care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/26350106251361370\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/8/19 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The science of diabetes self-management and care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/26350106251361370","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/19 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的本研究的目的是评估强化远程医疗干预对医疗补助计划中历史边缘青年糖尿病患者的技术采用和血糖控制的影响。方法本研究纳入12-18岁的青少年糖尿病患者,采用胰岛素治疗。符合条件的参与者在入组前至少12个月确诊,A1C≥9%,有医疗保险,愿意使用连续血糖监测仪(CGM)和胰岛素泵。参与者每周与认证的糖尿病护理和教育专家联系(电话/视频),每月与执业护士进行视频访问。结果青年(18例,女性61%,非白人78%,糖尿病病程4.6±3年)基线平均A1C为11.4%±2.0%;22%的患者接受泵治疗。在基线A1C(平均11.4%±2.0%)和3个月(平均10.5%±2.7%,P = 0.01)和6个月(平均9.8%±2.4%,83.6 mmol/mol, P = 0.003)之间持续改善。与基线(n = 4; P < 0.0001)相比,更多的参与者在结束时使用泵治疗(n = 16)。与3个月和6个月前相比,在干预期间,参与者在3个月(P = .04)和6个月(P = .0004)时佩戴cgm的次数更多。结论:这种远程医疗干预在历史上边缘化的低社会经济地位人群中提供了A1C的临时改善,并增加了糖尿病技术的采用。需要进行持续监测,以评估这一干预措施的持久性。
Telehealth to Promote Adoption of Automated Insulin Delivery Systems in Youth With Risk Factors for Adverse Diabetes Outcomes.
PurposeThe purpose of this study is to assess the effects of an intensive telehealth intervention on technology adoption and glycemic control in historically marginalized youth with diabetes mellitus on Medicaid.MethodsThis quality improvement project included youth (ages 12-18) with diabetes utilizing insulin therapy. Eligible participants were diagnosed at least 12 months prior to enrollment and had an A1C ≥9%, Medicaid insurance, and willingness to use a continuous glucose monitor (CGM) and an insulin pump. Participants received scheduled weekly contact (phone/video) with a certified diabetes care and education specialist and monthly video visits with a nurse practitioner.ResultsYouth (N = 18, 61% female, 78% non-White, diabetes duration 4.6±3 years) had baseline mean A1C of 11.4% ± 2.0%; 22% were on pump therapy. There was a sustained improvement between baseline A1C (mean 11.4% ± 2.0%) and 3 months (mean 10.5% ± 2.7%; P = .01) and 6 months (mean 9.8% ± 2.4%, 83.6 mmol/mol; P = .003). Significantly more participants used pump therapy by the end (n = 16) compared to baseline (n = 4; P < .0001). Participants wore CGMs more at 3 (P = .04) and 6 months (P = .0004) during the intervention compared to 3 and 6 months prior.ConclusionsThis telehealth intervention provided interim improvement in A1C and increased adoption of diabetes technology in a low socioeconomic status cohort from a historically marginalized population. Ongoing monitoring is needed to evaluate the durability of this intervention.